Select a relevant service

Evaluate data collected during drug development to maximize the value of a therapeutic product.

Find general strategies and methods used to market a pharmaceutical product or device.

Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.

Identify, measure and compare the cost-benefit ratio of products and services.

Compare alternative treatments that lead to similar health outcomes.

Develop value story tailored to a payer audience that will determine the appropriate price for treatment.

Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.

Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.

Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern submissions. See also AMCP and Value Dossier.

Develop strategy and narrative to gain formulary access on insurance plans.